The Everett Herald: Trump Order on Drug Prices Restricts Helpful Program”
Congress should protect a program that helps provide medications to patients most in need.
Modern Healthcare: Trump 340B Order Targets Clinics Serving the Poor
Trump 340B order targets clinics serving the poor
New Study Finds Hospitals Charge Nearly Two Times More Than Physician Offices for Same Cancer Treatments
WASHINGTON – New research from the Employee Benefit Research Institute (EBRI) has concluded that payments from private third-party payers for infused cancer medicines are,
New GAO Report Finds Oversight Lacking For 340B Hospitals
A new report from the Government Accountability Office (GAO) has concluded increased oversight is needed to ensure nongovernmental hospitals meet 340B eligibility
Drug Channels: PBM-Owned Specialty Pharmacies Expand Their Role In – and Profits From – the 340B Program
Last week, I documented that nearly half of U.S. pharmacies now participate in the 340B Drug Pricing Program. Below, we
Fierce Healthcare: Appeals court upholds nearly 30% payment cut to 340B hospitals
A federal appeals court has ruled the Trump administration can install nearly 30% cuts to the 340B drug discount program.
RealClearHealth: Congress Has no Clue About What’s Driving up Drug Prices
A coalition of think tanks and health care organizations – dubbed Lower Drug Prices Now – just launched a campaign
RealClearHealth: Hospitals Are Gaming the 340B Drug Program
The COVID-19 crisis has been a brutal lesson on the limitations of government action and imagination. The response, thus far,
Hospitals Serving Vulnerable Communities Chase Profits at the Expense of Patients
Patients across the country are receiving hospital care not knowing if they will get stuck with enormous and unexpected bills
AIR340B Coalition Reacts to Administration’s Announcement of Final Rule on Hospital Transparency Requirements
The Alliance for Integrity and Reform of 340B (AIR340B) issued the following statement regarding the 2020 Outpatient Prospective Payment System